Search

Zai Lab Ltd ADR

Avatud

SektorTervishoid

19.92 -2.73

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

20.06

Max

20.79

Põhinäitajad

By Trading Economics

Sissetulek

-607K

-51M

Müük

-28M

100M

Aktsiakasum

-0.46

Kasumimarginaal

-51.215

Töötajad

1,784

EBITDA

4.1M

-44M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+58.05% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

6. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-67M

2.3B

Eelmine avamishind

22.65

Eelmine sulgemishind

19.92

Uudiste sentiment

By Acuity

47%

53%

134 / 340 Pingereas Healthcare

Zai Lab Ltd ADR Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

22. juuli 2026, 23:56 UTC

Correlated Moves
News

American Water Works Company Inc. is trading lower in after-market hours amid geopolitical tensions and rising crude oil prices impacting market sentiment.

22. juuli 2026, 23:56 UTC

News

Wynn Resorts received approval to expand its Wynn Palace resort in Macau, including a new hotel and entertainment center. Shares showed little change in after-market trading.

22. juuli 2026, 23:51 UTC

News

Rollins Inc shares fell after second-quarter results missed expectations. Adjusted EPS was $0.32, below the consensus estimate of $0.34, amid slowing growth.

22. juuli 2026, 23:51 UTC

Social Media
News

CSX Corp reported second-quarter revenue of $3.94 billion and EPS of $0.54, exceeding expectations, leading to higher shares in after-market trading.

22. juuli 2026, 23:51 UTC

Social Media
News

Joby Aviation will release its Q2 2026 results on August 5, generating positive investor sentiment. Shares are trading higher in after-market hours.

22. juuli 2026, 23:51 UTC

Social Media
News

Southwest Airlines reported second-quarter earnings above estimates but missed on revenue, leading to shares trading lower in after-market hours.

22. juuli 2026, 23:51 UTC

News

Norfolk Southern Corp shares are trading lower in after-market hours following Union Pacific and Canadian National Railway's agreement that may impact its competitive position.

22. juuli 2026, 23:51 UTC

ETF Constituents
Social Media
News

Invesco QQQ Trust Series I is lower in after-market hours amid concerns over rising crude oil prices and geopolitical tensions affecting market sentiment.

22. juuli 2026, 23:51 UTC

Social Media
Correlated Moves
News

Amazon.com Inc is under Senate investigation for alleged Chinese influence on its marketplace, contributing to a decline in investor sentiment and stock price after hours.

22. juuli 2026, 23:51 UTC

ETF Constituents
News
Macro News

Vanguard Information Technology ETF is higher in after-market hours, driven by positive sentiment ahead of earnings from major tech firms and strong performances from key holdings.

22. juuli 2026, 23:46 UTC

News

EQT Corporation's stock rose after it raised full-year natural gas production guidance and secured long-term supply agreements, despite lower-than-expected earnings.

22. juuli 2026, 23:46 UTC

Social Media
News

Intel explores a partnership with SK Hynix for its Ohio facility. Shares are trading higher after securing Fortinet as its first external foundry customer.

22. juuli 2026, 23:46 UTC

Social Media
News

Crown Castle reported second-quarter adjusted FFO of $1.13, exceeding estimates. Shares are higher in after-market trading following the results and strategic business sale.

22. juuli 2026, 23:41 UTC

News

Goosehead Insurance shares rise in after-market hours following strong Q2 results, with revenue of $113.4 million and a leadership transition announcement.

22. juuli 2026, 23:41 UTC

News

Community Health Systems reported a significant decline in net income and lowered its full-year EPS guidance, leading shares to trade lower in after-market hours.

22. juuli 2026, 23:41 UTC

Social Media
News

Kinder Morgan's Q2 earnings of $0.37 per share exceeded estimates, driving shares higher in after-market trading. Revenue rose to $4.48 billion, surpassing expectations.

22. juuli 2026, 23:36 UTC

Social Media
Correlated Moves
News

Shutterstock shares are lower in after-market hours following the suspension of dividends and the resignation of Chief Accounting Officer Steven Ciardiello.

22. juuli 2026, 23:36 UTC

Correlated Moves
News

Microsoft shares are lower in after-market hours amid a securities class action lawsuit regarding its Copilot products and concerns over capital expenditures ahead of earnings.

22. juuli 2026, 23:36 UTC

Social Media
News

Rocket Lab shares are lower in after-market hours, reflecting broader sector trends. The company will release second-quarter 2026 results on August 10, 2026.

22. juuli 2026, 23:31 UTC

Social Media
News

Leslie's Inc shares declined in after-hours trading amid reports of a potential Chapter 11 bankruptcy, raising concerns about the company's financial stability.

22. juuli 2026, 23:26 UTC

News

Synopsys Inc will report third-quarter results on August 26, 2026, after market close. Shares are trading higher in after-market hours.

22. juuli 2026, 23:22 UTC

Social Media
News

Tesla Inc. shares declined in after-hours trading following a Q2 earnings miss, with adjusted EPS at $0.33 against expectations of $0.51.

22. juuli 2026, 23:22 UTC

Social Media
News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

22. juuli 2026, 23:16 UTC

News

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

22. juuli 2026, 23:16 UTC

News

Interactive Brokers reported second-quarter net revenue growth of 28% to $1.90 billion, driven by a 67% increase in customer margin loans.

22. juuli 2026, 23:11 UTC

Social Media
News

Lockheed Martin announced a quarterly dividend of $3.45 per share, boosting investor sentiment. Shares are higher in after-market trading following the announcement.

22. juuli 2026, 23:06 UTC

News

Constellation Energy Corp shares are lower in after-market trading, influenced by geopolitical tensions and concerns over potential oil supply disruptions.

22. juuli 2026, 23:06 UTC

News

Dollar Tree shares are lower in after-market trading amid scrutiny over new price scanners and rising costs, prompting concerns about customer loyalty.

22. juuli 2026, 23:06 UTC

News

General Motors raised its 2026 profit outlook to $14 billion to $16 billion, boosting shares higher in after-market hours following strong EBIT performance.

22. juuli 2026, 23:02 UTC

Social Media
News

QuantumScape Corp's shares declined in after-market hours following a narrower loss and lowered capital expenditures guidance amid concerns over future cash flow.

Võrdlus sarnastega

Hinnamuutus

Zai Lab Ltd ADR Prognoos

Hinnasiht

By TipRanks

58.05% tõus

12 kuu keskmine prognoos

Keskmine 32.4 USD  58.05%

Kõrge 44 USD

Madal 21.6 USD

Põhineb 4 Wall Streeti analüütiku instrumendi Zai Lab Ltd ADR 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

4 ratings

3

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

134 / 340 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat